OSE IMMUNOTHERAPEUTICS: eps_basic
| Value | {"amount": 1.71, "concept": "ifrs-full:BasicEarningsLossPerShare"} |
|---|---|
| Period | 2024-01-01 – 2024-12-31 |
| Status | current |
| Entity | OSE IMMUNOTHERAPEUTICS |
Provenance
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference:
Retrieved: 2026-08-23T22:30:45.671935+02:00
Raw response sha256:
Cite as: FACTANKER, https://factanker.com/fact/44ef0578-4faf-4af6-b727-771737905568
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference:
esef:969500HIUWVGY6NZSM05:2025-12-31Retrieved: 2026-08-23T22:30:45.671935+02:00
Raw response sha256:
1c030fbf6937c66989de5e264e1a01e4…Cite as: FACTANKER, https://factanker.com/fact/44ef0578-4faf-4af6-b727-771737905568
History
- no predecessors — first report